Oligodendrocyte Lineage In Multiple System Atrophy is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Multiple System Atrophy (MSA) is characterized by progressive oligodendroglial degeneration with the formation of glial cytoplasmic inclusions (GCIs). These inclusions contain aggregated alpha-synuclein, making MSA distinct from other synucleinopathies. The oligodendroglial pathology is central to disease pathogenesis and drives the white matter dysfunction and neurodegeneration seen in MSA.
- MBP (Myelin Basic Protein) - structural myelin protein
- PLP1 (Proteolipid Protein 1) - major myelin protein
- MOG (Myelin Oligodendrocyte Glycoprotein) - surface marker
- CNP (2',3'-Cyclic Nucleotide 3'-Phosphodiesterase) - enzyme marker
- OLIG2 - oligodendrocyte transcription factor 2
- SOX10 - transcription factor for oligodendrocyte lineage
- SNCA (Alpha-synuclein) - GCI main component
- p25α (PPP1R2A) - tubulin polymerization regulator
- HSP90 - heat shock protein
- Ubiquitin - inclusion marker
- TPPP/p25 - GCI-specific protein
¶ Anatomy and Distribution
- Striatonigral system: Putamen, caudate
- Cerebellar white matter: Middle cerebellar peduncle
- Brainstem: Pontine fibers
- Spinal cord: Lateral columns
- Cerebral white matter: Subcortical regions
- Internodal oligodendrocytes: Myelinate long axons
- Perineuronal oligodendrocytes: Surround neuron cell bodies
- Vascular oligodendrocytes: Associated with blood vessels
- Shape: Flame-shaped, tapered ends
- Location: Cell body and processes
- Composition: Alpha-synuclein filaments
- Distribution: Throughout white matter
- Prevalence: >90% of cases
- Myelin loss: Vacuolation, fragmentation
- Demyelination: Primary pathway
- Remyelination attempts: In early stages
- Oligodendrocyte death: Progressive
| Feature |
MSA |
PD |
AD |
| Main synuclein site |
Oligodendrocytes |
Neurons |
No synuclein |
| Inclusion type |
GCI |
LB |
None |
| Myelin loss |
Severe |
Mild |
Moderate |
- GCI formation: Oligodendroglial alpha-synuclein aggregation
- Propagation: Neuron-to-oligodendrocyte transmission
- Impaired clearance: Autophagy deficits
- Oxidative stress: Enhances aggregation
- Metabolic stress: Impaired oligodendrocyte function
- Iron accumulation: Promotes oxidative damage
- Lipid peroxidation: Myelin breakdown
- Energy failure: Mitochondrial dysfunction
- Microglial activation: Surrounding white matter
- Cytokine release: TNF-α, IL-1β
- Complement activation: Myelin elimination
- Astrocyte reactivity: In GCI-rich areas
- Secondary to demyelination: Energy deficits
- Primary oligodendrogliopathy: Driving force
- Dystrophic axons: In GCI regions
- Parkinsonism: Bradykinesia, rigidity
- Cerebellar ataxia: Gait instability
- Autonomic failure: Orthostatic hypotension
- Stridor: Laryngeal dysfunction
- Cognitive impairment: Executive dysfunction
- Sleep disorders: REM behavior disorder
- Depression: Common in MSA
- Symptomatic treatment: Dopaminergic medications
- Autonomic management: Fludrocortisone, midodrine
- Physical therapy: Maintain function
- Alpha-synuclein targeting: Immunotherapy
- Myelin protection: Promote oligodendrocyte survival
- Neurotrophic support: GDNF delivery
- Anti-inflammatory agents: Microglial modulation
The study of Oligodendrocyte Lineage In Multiple System Atrophy has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Wenning GK, et al. (2004). "Multiple system atrophy: a review of 203 pathologically proven cases." Mov Disord. 19(9):1032-1042.
- Jellinger KA, et al. (2014). "Alpha-synuclein in the brain: the dual role in health and disease." Nat Rev Neurol. 10(2):93-106.
- Singer W, et al. (2017). "Neurodegeneration with brain iron accumulation: update on pathogenesis." J Parkinsons Dis. 7(4):541-558.
- Ubhi K, et al. (2010). "Oligodendrogliopathy in multiple system atrophy: role of the alpha-synuclein." Neurobiol Dis. 40(2):293-304.
- Brück A, et al. (2016). "In vivo diffusion tensor imaging in multiple system atrophy." J Neurol Neurosurg Psychiatry. 87(9):1022-1029.